PHGE - BiomX Inc.
5.75
-0.550 -9.565%
Share volume: 107,635
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$6.30
-0.55
-0.09%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 11-14-2024 | 03-25-2025 | 05-15-2025 | 08-13-2025 | 11-12-2025 | 02-19-2026 | |
| Cash flow financing | 0.000 | -398.000 K | 11.913 M | -29.000 K | 54.000 K | 1.251 M | |
| Other financing cash flows | 0.000 | -398.000 K | 6.473 M | -6.471 M | 6.473 M | 0.000 | |
| Cash flow | 0.000 | -6.688 M | 3.252 M | -6.080 M | -7.131 M | -3.134 M | |
| Net income | 9.642 M | -14.513 M | -7.659 M | -6.037 M | -9.166 M | -13.337 M | |
| Depreciation | 322.000 K | 921.000 K | 236.000 K | 292.000 K | 1.241 M | 1.153 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -1.000 K | -1.000 K | 51.000 K | 58.000 K | -2.000 K | 1.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 10.000 K | 11.000 K | -51.000 K | -58.000 K | 2.000 K | 0.000 | |
| Cash Change | -8.098 M | -6.688 M | 3.252 M | -6.080 M | -7.131 M | -3.134 M |